drugset / Trial / NCT02009527

Arginase Inhibition in Ischemia-reperfusion Injury

NCT02009527 ↗

Phase 1 Completed 24 enrolled Karolinska Institutet
RandomizedCrossoverSingle-blindBasic science

Summary

The present project is designed to test the hypothesis that arginase contributes to endothelial dysfunction induced by ischemia-reperfusion in patients with coronary artery disease.

Timeline

Start
2012-01
Primary completion
2013-04
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Subject N-hydroxy-nor-arginine Unknown 0.1 mg Other